Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare...
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening Toronto...
Predictmedix Announces Production of AI-Powered Mobile Application to Detect Impairment from Alcohol and Cannabis Predictmedix has...
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia The...
Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector DefSpace, a global...
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at...
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce...
DALLAS, Dec. 27 /PRNewswire/ -- Beacon Equity Research announces the availability of TraderNotes on stocks that are making news...
NEW YORK, Feb. 9 /PRNewswire/ -- On February 7, Ray Cannefax, CEO of Paradigm Medical Industries, Inc. (OTC:PMED) (BULLETIN BOARD: PMED...
Paradigm Medical Third Quarter Net Income $37,000, Sales Increase 32% SALT LAKE CITY, Nov. 17 /PRNewswire-FirstCall/ -- Paradigm Medical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.